Buy Torrent Pharmaceuticals, target of Rs 260: Sharekhan
Sharekhan has maintianed its buy rating on Torrent Pharmaceuticals with a target price of Rs 260 in its June 04, 2009 research report.
“Torrent’s Q4FY2009 performance has been marginally ahead of our expectations both on revenue and profit fronts. The company’s efforts to improve its international businesses seem to be yielding fruits, as is seen in the improving performance of Heumann and the robust growth across all other international geographies. The domestic business, which accounts for 50% of the turnover, has also recovered and is expected to outperform the market in the coming quarters. Strong revenue traction, improving product mix and cost rationalisation will facilitate the company’s upward margin bias. Lastly, with Torrent strengthening its presence in the US market would act as a strong growth driver (on a low base) in the coming years. We roll over our valuations to the FY2011 earnings estimate and maintain our Buy recommendation on the stock with a price target of Rs 260, ” says Sharekhan’s research report.
Tags: brokerage calls and tips, buy or sell torrent pharma, buy rating, NSE Tips, share khan, Torrent Pharmaceuticals
Similar Posts:
Latest Query
- by Sam
Market Stats
Search Our Archives
Research Desk
- Stocks Trading above their 50 day moving average - DMA In Stock Research
- Download free Ebooks based on Technical Analysis In Personal Training
- TOP 100 Stocks with the Highest P/E as on July 14th, 2013 In Stock Research
- TOP 100 Stocks with the Lowest P/E as on July 14th, 2013 In Stock Research
- Charting Pathsala - Your guide to Techincals In Technical Analysis
